COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing.

Peto T, UK COVID-19 Lateral Flow Oversight Team

Open source

DOI
10.1016/j.eclinm.2021.100924
Published
2021 Jun
Container
EClinicalMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2021.100924,
  title = {COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing.},
  author = {Peto T and UK COVID-19 Lateral Flow Oversight Team},
  year = {2021},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2021.100924},
  url = {https://doi.org/10.1016/j.eclinm.2021.100924}
}

RIS

TY  - JOUR
TI  - COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing.
AU  - Peto T
AU  - UK COVID-19 Lateral Flow Oversight Team
PY  - 2021
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2021.100924
UR  - https://doi.org/10.1016/j.eclinm.2021.100924
ER  - 

APA

T, P., & Team, U. C. L. F. O. (2021). COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2021.100924

Source records